CONFERENCES

      European Molecular Biology Laboratory

      The European Molecular Biology Laboratory (EMBL) is part of a special project of the European Molecular Biology Conference (EMBC). The EMBL supports European cooperation in fundamental molecular biology research, provides the necessary infrastructure and contributes to the ongoing development of cutting-edge instruments and methods for modern biology. EMBL delivers world-class courses, conferences and workshops at the forefront of molecular life science and its applications.

      EMBO | EMBL Symposium: The human microbiome 2023

      Date

      Sep 20, 2023 - Sep 23, 2023

      Location

      Heidelberg, Germany

      Online

      For 2023, sessions focus on the human microbiome across biological time and in nutrition and drugs, host-microbe interactions, integrative approaches in microbiome research, methodological advances in microbiome analysis, and future of microbiome research and translation.

      EMBL–Wellcome Connecting Science Conference: Proteomics in Cell Biology and Disease Mechanisms 2018

      Date

      Feb 28, 2018 - Mar 02, 2018

      Location

      Cambridge, U.K.

      This is an annual conference on novel proteomics approaches to study long-standing questions in cell biology and disease mechanisms, with topics ranging from systems biology to clinical proteomics

      EMBO | EMBL Symposium: From Single- to Multiomics: Applications and Challenges in Data Integration 2017

      Date

      Nov 12, 2017

      Location

      Heidelberg, Germany

      This is a biennial conference that focuses on new ideas for integrating and interpreting data across the different "omics" technologies, with topics ranging from metabolomics to genomics. 

      EMBO | EMBL Symposium: The Non-Coding Genome 2017

      Date

      Sep 13, 2017 - Sep 16, 2017

      Location

      Heidelberg, Germany

      The conference has for theme this year "Seeing is Believing - Imaging the Processes of Life" and brings together the leading developers of imaging methods with cutting-edge applications that illustrate how imaging can answer biological questions. 

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts in support of its smoke-free product portfolio. This site is a global site for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not advertising or marketing, nor is it directed at any specific market. It is not intended for use by consumers. New tobacco products sold in the United States are subject to FDA regulation; therefore the content of this site is not intended to make, and nor should it be construed as making, any product related claims in the United States without proper FDA authorization. ​
      ​
      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. All of our RRPs are smoke-free products that deliver nicotine with far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.